Collegium Pharmaceutical, Inc. (COLL)
NASDAQ: COLL · Real-Time Price · USD
26.18
+0.20 (0.77%)
Aug 12, 2026, 1:24 PM EDT - Market open
Collegium Pharmaceutical Market Cap
Collegium Pharmaceutical has a market cap or net worth of $852.31 million as of August 12, 2026. Its market cap has decreased by -25.14% in one year.
Market Cap
852.31M
Enterprise Value
1.94B
1-Year Change
-25.14%
Ranking
Category
Stock Price
$26.18
ChartMarket Cap Chart
Since May 7, 2015, Collegium Pharmaceutical's market cap has increased from $242.20M to $852.31M, an increase of 251.90%. That is a compound annual growth rate of 11.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 852.31M | -41.77% |
| Dec 31, 2025 | 1.46B | 58.40% |
| Dec 31, 2024 | 924.00M | -7.95% |
| Dec 29, 2023 | 1.00B | 28.87% |
| Dec 30, 2022 | 778.90M | 20.63% |
| Dec 31, 2021 | 645.70M | -6.79% |
| Dec 31, 2020 | 692.70M | 0.39% |
| Dec 31, 2019 | 690.00M | 20.86% |
| Dec 31, 2018 | 570.90M | -5.02% |
| Dec 29, 2017 | 601.10M | 34.93% |
| Dec 30, 2016 | 445.50M | -21.69% |
| Dec 31, 2015 | 568.90M | 134.89% |
| May 7, 2015 | 242.20M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Xeris Biopharma Holdings | 1.46B |
| Phibro Animal Health | 1.39B |
| Alvotech | 1.35B |
| Eton Pharmaceuticals | 1.20B |
| Cronos Group | 1.16B |
| Pacira BioSciences | 973.83M |
| Glass House Brands | 897.72M |
| Amphastar Pharmaceuticals | 863.95M |